Cryosite Ltd. | Cash Flow

Fiscal year is July-June. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,250.00
505.60
455.20
302.50
225.10
1,240.40
Depreciation, Depletion & Amortization
582.80
597.60
652.70
664.40
587.70
424.10
Other Funds
-
-
2,343.00
-
500.00
540.80
Funds from Operations
1,917.30
1,594.10
1,305.50
1,092.50
386.40
220.70
Changes in Working Capital
189.90
198.70
264.70
535.00
1,315.80
0.60
Net Operating Cash Flow
2,107.20
1,792.70
1,570.30
557.50
1,702.20
220.10
Capital Expenditures
379.20
683.00
626.30
587.60
296.10
Net Investing Cash Flow
379.20
683.00
626.30
587.60
296.10
Cash Dividends Paid - Total
475.70
700.60
685.90
485.60
468.60
Net Financing Cash Flow
475.70
634.60
3,028.80
485.60
31.40
Net Change in Cash
1,252.30
475.10
2,084.90
515.70
1,437.50
Free Cash Flow
1,728.10
1,365.10
1,090.10
171.10
1,506.20
Deferred Taxes & Investment Tax Credit
69.00
248.60
153.60
136.80
109.20
54.80
Change in Capital Stock
-
66.00
-
-
-

About Cryosite

View Profile
Address
13a Ferndell Street
South Granville New South Wales (NSW) 2142
Australia
Employees -
Website http://www.cryosite.com
Updated 07/08/2019
Cryosite Ltd. provides outsourced logistics services to clients including the research, medical, pharmaceutical, veterinary and biotechnology industries. It operates through the following segments: Individualised Consumer Biologics, and Scientific Processing and Logistics. The Individualised Consumer Biologics segment involves the activities of the private cord blood service, adult stem cell storage and general bio-repository management.